Across TCGA pan-cancer cohorts, LINC00703 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC00703’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC00703 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00703 is over-expressed in tumor, although a few such as KIRC and READ show the opposite, repressed pattern.
KIRC, HNSC, and READ are the cancer types where LINC00703 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00703 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.